We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Forty-eight states were involved in a price-fixing investigation that has now led to multi-state and multimillion-dollar litigation against some of the largest generics makers, a newly revealed complaint shows. Read More
Acting FDA Commissioner Ned Sharpless issued another warning to violative stem cell manufacturers following a judge’s permanent injunction against two Florida clinics on Tuesday, promising that the agency’s “aggressive oversight” will continue. Read More
A bipartisan group of U.S. lawmakers introduced a bill aimed at increasing the availability of over-the-counter medications to help bring down healthcare costs. Read More
AbbVie sent shockwaves through the drug industry Tuesday, announcing that it had reached a deal to acquire fellow drug giant Allergan for approximately $63 billion. Read More